In this randomized trial, the use of cerebral embolic protection (CEP) did not decrease the 72-hour incidence of stroke in ...

In this randomized controlled trial, treatment with nerandomilast led to slower declines in forced vital capacity (FVC) in patients with progressive pulmonary fibrosis over 52 weeks 2. The occurrence ...